Lumosa Therapeutics Co., Ltd. announced a private placement of 70,000,000 common shares on March 10, 2023. Board of directors will be authorized to execute the private placement once or twice after the annual shareholders meeting. If the board of directors decides to execute the private placement at twice, the first amount of private shares will not exceed 50,000,000 shares, the second amount will not exceed 20,000,000 shares.

The transaction has been approved by the shareholder's of the company.